SAN DIEGO--(BUSINESS WIRE)--Dalrada Corporation (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that appointed to its Board of Directors are The Honorable Bijan R. Kian, Jose Arrieta, and Kyle McCollum.
Dalrada’s CEO, Brian Bonar, states, “Dalrada is excited to report new growth with its Board of Directors that expands and accelerates the Company’s global initiatives in engineering & technology, health, and clean energy. The Hon. Bijan R. Kian, Jose Arrieta, and Kyle McCollum are known for their extensive industry experience in global trade & international security, disruptive emerging technologies, and global finance, respectively. Dalrada’s Board members are an exceptional team of world leaders who embrace and support the Company’s vision.”
Driven by passionate and dedicated people, Dalrada is a global innovation company that introduces evidence-based, disruptive products and services and spearheads innovation in areas that benefit industrial, commercial, and consumer markets. The Company works continually to produce solutions that bridge the gap of accessibility and accelerate positive change for current and future generations. Dalrada’s scalable supply chain is effective and efficient, resulting in significant cost savings for the Company, its clients, and their customers.
THE HONORABLE BIJAN R. KIAN
Twice confirmed by the United States Senate, Bijan has served three presidents of the United States from both major political parties. Formerly, he served as a:
- Deputy Lead on the Office of Director of National Intelligence for the Presidential Transition Team
- Member of the Board of Directors of the Export-Import Bank of the United States
- Member of White House Business Council
- Director of Foreign Investment for the State of California
- Senior Fellow for global public policy at the United States Naval Postgraduate School
- Member of the Board of Directors at National Defense University Foundation
The Hon. Bijan R. Kian is recognized around the world as a senior executive in global trade and international security. A graduate of the University of Brighton in 1979, he continued his education at Oxford, Harvard Kennedy School, and MIT. A Fellow at the Royal Society of Arts in the United Kingdom, he is also the recipient of the Ellis Island Medal of Honor, also awarded to seven presidents of the United States.
JOSE ARRIETA
The former Chief Information Officer and Interim Chief Data Officer of HHS, Mr. Jose Arrieta is a respected leader in applying emerging technologies – especially blockchain, artificial intelligence/machine learning, and process automation. He oversaw $6.3B in IT investments, $800B in grants, and $26B in Federal contracts in his last three years at HHS.
Mr. Arrieta has published articles on valuing disruptive technology companies and the importance of industry-government communications. He led the creation and implementation of the largest public health surveillance capability in the United States during the pandemic and the first enterprise-grade supervised machine learning capability to help more accurately distribute testing supplies and predict hot spots across the country. Mr. Arrieta created a public-private key and distributed ledger infrastructure to establish digital identities for commercial, Federal, and state endpoints to aid the COVID-19 vaccination and testing efforts.
At Johns Hopkins University, Mr. Arrieta created and teaches the first blockchain course (blockchain and cryptos) as well as entrepreneurial finance. Before his work with the U.S. government, Mr. Arrieta founded imagineeer, an IT solutions company that currently is focused on fundraising, blockchain-enabled diagnostic equipment, cybersecurity solutions, and quantum-inspired optimization capabilities.
Mr. Arrieta works with Federal customers evaluating and valuing venture-backed technology start-ups in health and the national security space. He currently sits on multiple boards and advises five technology start-ups. Imagineeer is also working to build an ecosystem to facilitate secure, autonomous, data-driven, AI-powered, science-based organizations.
KYLE MCCOLLUM, CPA
Dalrada’s Chief Financial Officer, Mr. Kyle McCollum, CPA, holds over 17 years’ experience in accounting, finance, and management, both domestically and internationally. He brings expertise across a broad spectrum of industries and functionalities including accounting & finance, investment strategy, due diligence, mergers & acquisitions, compliance, fund structuring, fundraising, and investor relations.
Before joining Dalrada, Mr. McCollum oversaw financial operations for publicly traded and privately held companies. He has served industries including pet health and wellness, real estate investment & development, mining, and nutraceuticals. Mr. McCollum earned a Bachelor of Science and a Master of Accountancy degree from the University of Montana.
Dalrada’s Board of Directors is now composed of:
- Brian Bonar, Dalrada Founder & CEO – Technology & Engineering
- Jose Arrieta – Technology & Automation
- Dr. David Bacon – Healthcare
- Tom Giles – Technology & Clean Energy
- Pauline Gourdie – Supply Chain & Recruitment
- Harvey Hershkowitz – Healthcare & Technology
- Brian Kendrick – Aviation & Acquisitions
- The Hon. Bijan R. Kian – Global Trade & International Security
- Kyle McCollum – Domestic & International Finance
- Fawad Nisar – Operations, Science & Engineering, Brand & Marketing & Tech
- Fletcher Robbe – Legal & Finance
- Anthony Zolezzi – Sustainability & Technology
On a global scale, Dalrada creates evidence-based, disruptive solutions that are sustainable, affordable, accessible, and socially responsible. For additional information, visit www.dalrada.com.
About Dalrada Corporation (DFCO)
With perseverance, valor, dedication, and vision, Dalrada Corporation is dedicated to tackling worldwide challenges of today and tomorrow.
Dalrada is a global company that operates under the tenet of creating impactful innovations that matter for the world. The Company works continually to produce disruptive solutions that bridge the gap of accessibility and accelerate positive change for current and future generations.
Established in 1982, the Company has since grown its footprint to include the business divisions: Dalrada Health, Dalrada Precision, and Dalrada Technologies. Each of Dalrada’s subsidiaries actively produces affordable and accessible world-class solutions to global problems. For more information, please visit www.dalrada.com.
Disclaimer
Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.
